INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2023 | $3 | -50.0% | 8 | 0.0% | 0.00% | – |
Q1 2023 | $6 | – | 8 | – | 0.00% | – |
Q4 2022 | $0 | – | 0 | – | 0.00% | – |
Q3 2022 | $0 | – | 0 | – | 0.00% | – |
Q2 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q1 2022 | $1,000 | -66.7% | 294 | -42.7% | 0.00% | – |
Q4 2021 | $3,000 | -25.0% | 513 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | -87.9% | 513 | -85.4% | 0.00% | -100.0% |
Q2 2021 | $33,000 | +17.9% | 3,513 | +17.1% | 0.00% | 0.0% |
Q1 2021 | $28,000 | +3.7% | 3,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $27,000 | +575.0% | 3,000 | +728.7% | 0.00% | – |
Q3 2020 | $4,000 | -20.0% | 362 | +77.5% | 0.00% | – |
Q2 2020 | $5,000 | -28.6% | 204 | -79.6% | 0.00% | -100.0% |
Q1 2020 | $7,000 | – | 1,000 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | – | 0 | – | 0.00% | – |
Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Q1 2019 | $0 | – | 0 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
Keystone Financial Group | 109,897 | $42,751 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |